As of Feb 27
| -0.10 / -0.63%|
The 12 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 22.21, with a high estimate of 25.66 and a low estimate of 15.99. The median estimate represents a +40.56% increase from the last price of 15.80.
The current consensus among 12 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.